# Eyesee

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eyesee

- Industry: Healthcare Specialists
- Headquarters: Chengdu, China
- Website: www.eyesee8.com
- Latest round: Angel (Nov 10, 2017)
- Investors on record: 1

## About

Founded in 2016 and based in Chengdu, China, Eyesee operates as a medical company that focuses on providing fundus screening medical services. It was recognized as the National High-tech Enterprise. Jin Cao, the chairman of the company, graduated from Peking University. He used to be a marketing executive of Yuanda Group and executive vice president of Ashir Capital in the United States. The company cooperates with tertiary hospitals such as West China Hospital of Sichuan University and Sichuan Provincial People's Hospital. In November 2017, Eyesee closed an angel funding from new investor Guoqian Venture Capital.

The company's main business is fundus screening medical services. Based on fundus screening artificial intelligence analysis technology, it provides patients with remote film reading diagnosis services, fundus disease screening, and other services.

The company generates revenue by providing fundus screening and related medical services.

## Funding rounds

- Angel, Nov 10, 2017 — Guoqian Venture Capital

## Investors

- Guoqian Venture Capital (https://capitalatlas.ai/funds/guoqian-venture-capital) — Angel